Back to Hawaii

HR22 • 2026

URGING THE UNITED STATES CONGRESS TO PASS H.R. 2687, ALSO KNOWN AS THE END KIDNEY DEATHS ACT.

URGING THE UNITED STATES CONGRESS TO PASS H.R. 2687, ALSO KNOWN AS THE END KIDNEY DEATHS ACT.

Taxes
Active

The official status still shows this bill as active or still awaiting another formal step.

Sponsor
TAKAYAMA, BELATTI, GARCIA, IWAMOTO, KITAGAWA, KUSCH, MARTEN, MURAOKA, OLDS, PERRUSO, REYES ODA, TAM
Last action
2026-04-09
Official status
Resolution adopted in final form.
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

URGING THE UNITED STATES CONGRESS TO PASS H.R. 2687, ALSO KNOWN AS THE END KIDNEY DEATHS ACT.

URGING THE UNITED STATES CONGRESS TO PASS H.R.

What This Bill Does

  • URGING THE UNITED STATES CONGRESS TO PASS H.R.
  • 2687, ALSO KNOWN AS THE END KIDNEY DEATHS ACT.
  • Kidney Disease; Kidney Donation; Tax Credits; End Kidney Deaths Act

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-04-09 H

    Resolution adopted in final form.

  2. 2026-04-09 H

    Adopted with none voting aye with reservations; none voting no (0) and Representative(s) Cochran excused (1).

  3. 2026-04-09 H

    Reported from JHA (Stand. Com. Rep. No. 1879-26), recommending adoption.

  4. 2026-04-07 H

    The committee on JHA recommend that the measure be PASSED, UNAMENDED. The votes were as follows: 6 Ayes: Representative(s) Tarnas, Poepoe, Belatti, Takayama, Garcia, Shimizu; Ayes with reservations: none; Noes: none; and 4 Excused: Representative(s) Hashem, Kahaloa, Sayama, Cochran.

  5. 2026-04-02 H

    Resolution scheduled to be heard by JHA on Tuesday, 04-07-26 2:00PM in conference room 325 VIA VIDEOCONFERENCE.

  6. 2026-04-01 H

    Report adopted; referred to the committee(s) on JHA with none voting aye with reservations; none voting no (0) and none excused (0).

  7. 2026-04-01 H

    Reported from HLT (Stand. Com. Rep. No. 1591-26), recommending referral to JHA.

  8. 2026-03-25 H

    The committee on HLT recommend that the measure be PASSED, UNAMENDED. The votes were as follows: 9 Ayes: Representative(s) Takayama, Keohokapu-Lee Loy, Amato, Hartsfield, Marten, Olds, Takenouchi, Alcos, Garcia; Ayes with reservations: none; Noes: none; and Excused: none.

  9. 2026-03-20 H

    Resolution scheduled to be heard by HLT on Wednesday, 03-25-26 9:30AM in conference room 329 VIA VIDEOCONFERENCE.

  10. 2026-03-10 H

    Referred to HLT, JHA, referral sheet 15

  11. 2026-03-05 H

    Offered

  12. 2026-03-03 H

    To be offered.

Official Summary Text

URGING THE UNITED STATES CONGRESS TO PASS H.R. 2687, ALSO KNOWN AS THE END KIDNEY DEATHS ACT.
Kidney Disease; Kidney Donation; Tax Credits; End Kidney Deaths Act

Current Bill Text

Read the full stored bill text
HR22

HOUSE OF REPRESENTATIVES

H.R. NO.

22

THIRTY-THIRD LEGISLATURE, 2026

STATE OF HAWAII

HOUSE RESOLUTION

urging the united states congress to pass H.r. 2687, also
known as the end kidney deaths act
.

����
WHEREAS,
kidney disease and kidney failure are serious, life-threatening medical
conditions that disproportionately impact people of color; and

����
WHEREAS, currently
more than five thousand Hawaii residents rely on dialysis and hundreds die each
year; and

����
WHEREAS, patients
from rural and low-income communities are significantly more likely to die from
kidney disease due to the deep inequities in access to timely and effective
treatment; and

����
WHEREAS, of
the nearly ninety-five thousand Americans nationwide who are waiting for a
kidney transplant, several thousands die each year, despite kidney
transplantation being a proven, life-saving therapy; and

����
WHEREAS, while
dialysis can sustain a patient's life, it also significantly diminishes quality
of life, shortens life expectancy, and imposes substantial physical, emotional,
and financial burdens on patients and families; and

����
WHEREAS, the
federal government spends approximately $50,000,000,000 annually on dialysis
care, which represents nearly one percent of all federal spending; and

����
WHEREAS, kidney
transplantation not only restores health and independence for patients but also
reduces long-term public expenditures, with each transplant estimated to save
approximately $500,000 compared to the lifetime cost of dialysis; and

����
WHEREAS, expanding
access to kidney transplantation has the potential to save up to ten thousand
lives each year and reduce federal health care spending by approximately
$4,000,000,000 annually; and

����
WHEREAS, living
donor kidney transplants are widely recognized as the gold standard of kidney
care, offering better outcomes and longer graft survival than deceased donor
transplants; and

����
WHEREAS, living
kidney donation is already among the most tightly regulated medical procedures
in the United States, with comprehensive medical, psychological, and ethical
safeguards to protect donor safety and prevent coercion; and

����
WHEREAS, the
number of living kidney donors has remained largely unchanged for more than
twenty-five years, demonstrating that existing policies have failed to meet the
growing need for donors; and

����
WHEREAS, H.R.
2687, also known as the End Kidney Deaths Act, was introduced on April 7, 2025,
to the 119th Congress; and

����
WHEREAS, the
End Kidney Deaths Act would allow for regulated, refundable tax credits for individuals
who donate a kidney to a stranger; and

����
WHEREAS, providing
tax credits for non-directed living donation recognizes the burdens of donation
while preserving existing donor protections; and

����
WHEREAS, non-directed
kidney donation can initiate transplant changes that save multiple lives from a
single act of generosity; and

����
WHEREAS, the
End Kidney Deaths Act is a bipartisan, evidence-based proposal that address
human suffering and fiscal responsibility; now, therefore,

����
BE IT
RESOLVED by the House of Representatives of the Thirty-third Legislature of the
State of Hawaii, Regular Session of 2026, that this body urges the United
States Congress to pass H.R. 2687, also known as the End Kidney Deaths Act; and

����
BE IT FURTHER
RESOLVED that this body urges Hawaii's congressional delegation to support the
End Kidney Deaths Act as a means of saving lives, reducing health inequities
that affect rural and low-income communities, and improving the sustainability
of the nation's health care system; and

����
BE IT FURTHER
RESOLVED that certified copies of this Resolution be transmitted to the
President of the United States, Speaker of the United States House of
Representatives, President Pro Tempore of the United States Senate, and members
of Hawaii's congressional delegation.

OFFERED BY:

_____________________________

Report Title:
�

Kidney
Disease; Kidney Donation; Tax Credits; End Kidney Deaths Act